Conestoga Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,500
| Closed | -$330K | – | 136 |
|
|
2024
Q1 | $330K | Hold |
2,500
| – | – | ﹤0.01% | 122 |
|
|
2023
Q4 | $273K | Hold |
2,500
| – | – | ﹤0.01% | 127 |
|
|
2023
Q3 | $257K | Hold |
2,500
| – | – | ﹤0.01% | 123 |
|
|
2023
Q2 | $288K | Hold |
2,500
| – | – | ﹤0.01% | 120 |
|
|
2023
Q1 | $266K | Hold |
2,500
| – | – | ﹤0.01% | 126 |
|
|
2022
Q4 | $277K | Hold |
2,500
| – | – | 0.01% | 125 |
|
|
2022
Q3 | $215K | Hold |
2,500
| – | – | ﹤0.01% | 134 |
|
|
2022
Q2 | $228K | Hold |
2,500
| – | – | ﹤0.01% | 136 |
|
|
2022
Q1 | $205K | Buy |
+2,500
| New | +$197K | ﹤0.01% | 139 |
|
|
2021
Q1 | – | Sell |
-6,969
| Closed | -$544K | – | 148 |
|
|
2020
Q4 | $544K | Hold |
6,969
| – | – | 0.01% | 120 |
|
|
2020
Q3 | $552K | Hold |
6,969
| – | – | 0.01% | 116 |
|
|
2020
Q2 | $514K | Hold |
6,969
| – | – | 0.01% | 119 |
|
|
2020
Q1 | $512K | Hold |
6,969
| – | – | 0.02% | 101 |
|
|
2019
Q4 | $605K | Hold |
6,969
| – | – | 0.01% | 102 |
|
|
2019
Q3 | $560K | Hold |
6,969
| – | – | 0.01% | 90 |
|
|
2019
Q2 | $558K | Hold |
6,969
| – | – | 0.01% | 93 |
|
|
2019
Q1 | $553K | Hold |
6,969
| – | – | 0.02% | 91 |
|
|
2018
Q4 | $508K | Sell |
6,969
-262
| -4% | -$18.5K | 0.02% | 89 |
|
|
2018
Q3 | $489K | Hold |
7,231
| – | – | 0.01% | 97 |
|
|
2018
Q2 | $419K | Hold |
7,231
| – | – | 0.01% | 102 |
|
|
2018
Q1 | $376K | Hold |
7,231
| – | – | 0.01% | 102 |
|
|
2017
Q4 | $388K | Sell |
7,231
-734
| -9% | -$40.7K | 0.01% | 102 |
|
|
2017
Q3 | $487K | Sell |
7,965
-419
| -5% | -$25.4K | 0.02% | 89 |
|
|
2017
Q2 | $513K | Hold |
8,384
| – | – | 0.03% | 82 |
|
|
2017
Q1 | $508K | Hold |
8,384
| – | – | 0.03% | 79 |
|
|
2016
Q4 | $471K | Hold |
8,384
| – | – | 0.03% | 77 |
|
|
2016
Q3 | $499K | Hold |
8,384
| – | – | 0.03% | 74 |
|
|
2016
Q2 | $461K | Hold |
8,384
| – | – | 0.03% | 74 |
|
|
2016
Q1 | $423K | Hold |
8,384
| – | – | 0.03% | 72 |
|
|
2015
Q4 | $423K | Sell |
8,384
-524
| -6% | -$26.4K | 0.03% | 74 |
|
|
2015
Q3 | $420K | Hold |
8,908
| – | – | 0.03% | 72 |
|
|
2015
Q2 | $484K | Hold |
8,908
| – | – | 0.03% | 67 |
|
|
2015
Q1 | $489K | Hold |
8,908
| – | – | 0.03% | 71 |
|
|
2014
Q4 | $483K | Hold |
8,908
| – | – | 0.03% | 71 |
|
|
2014
Q3 | $504K | Hold |
8,908
| – | – | 0.04% | 60 |
|
|
2014
Q2 | $492K | Hold |
8,908
| – | – | 0.03% | 68 |
|
|
2014
Q1 | $483K | Sell |
8,908
-1,048
| -11% | -$54.3K | 0.03% | 78 |
|
|
2013
Q4 | $475K | Sell |
9,956
-105
| -1% | -$4.8K | 0.03% | 81 |
|
|
2013
Q3 | $457K | Sell |
10,061
-209
| -2% | -$9.54K | 0.04% | 71 |
|
|
2013
Q2 | $455K | Buy |
+10,270
| New | +$459K | 0.05% | 70 |
|
Other funds holding MRK
Conestoga Capital Advisors's MRK Position: Q2 2024 in Review
Conestoga Capital Advisors sold out of Merck (MRK) in Q2 2024, closing a stake of 2,500 shares — an estimated $330K sold.
Conestoga Capital Advisors first reported a position in MRK in Q2 2013 and held it in 40 quarters. The position peaked at $605K in Q4 2019. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.
- Conestoga Capital Advisors reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
- Conestoga Capital Advisors sold 2,500 Merck shares in Q2 2024, an estimated $330K.
- Conestoga Capital Advisors first reported a position in Merck in Q2 2013 and held it in 40 quarters.
- Conestoga Capital Advisors's Merck position peaked at $605K in Q4 2019.
- 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.
Based on Conestoga Capital Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.